SANTA CLARA, Calif., June 28, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified ...
Now available in the U.S., the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter safely modifies and crosses occlusive or extremely narrowed calcific peripheral artery disease SANTA ...
Shockwave Medical Inc. said Tuesday that its intravascular lithotripsy (IVL) therapy has won U.S. FDA approval for the treatment of severe coronary artery disease (CAD). The technology, which was ...
Approvals Cover Both Coronary and Peripheral IVL Catheters and Generators Manufactured by Shockwave About Shockwave Medical, Inc.Shockwave is focused on developing and commercializing products ...
WASHINGTON (January 10, 2023) – In recent years, transcatheter mitral valve replacement (TMVR) treatment and technology has evolved, but procedure-related morbidity remains a concern. A new study ...
SANTA CLARA, Calif., April 13, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified ...
As we move towards year-end 2023, I am assembling a list of potential healthcare tickers that are worthy of consideration for a spot in one of my three healthcare portfolios (speculative, growth, ...
Add Yahoo as a preferred source to see more of our stories on Google. Kevin Wininger, a computed tomography technologist and cardiovascular technologist at University Hospital’s Samaritan Medical ...
Shockwave Medical is a pioneer in intravascular lithotripsy and has recently experienced a reset valuation due to temporary factors. The company has shown strong revenue growth in 2023, but is facing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results